EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Chasing the target: reports from the Advances in Targeted Therapies meeting, 2025

Kevin L Winthrop, Andreas Kerschbaumer, John D Isaacs, Philip Mease, Xenofon Baraliakos, Mary K Crow, Maya Buch, Stefan Siebert, Neil Basu, Philip Conaghan, Margreet Kloppenburg, Oliver Distler und 10 weitere

Annals of the Rheumatic Diseases · 2026

DOI: 10.1016/j.ard.2026.03.024 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Annals of the Rheumatic Diseases, 2026. Verfasst von Kevin L Winthrop und 21 weiteren Autor:innen. Beteiligte Einrichtung: Oregon Health and Science University, Portland, OR, USA. Electronic address: Winthrop@ohsu.edu. Hauptthemen laut MEDLINE: Molecular Targeted Therapy, Rheumatology, Rheumatic Diseases, Antirheumatic Agents. Die Arbeit nennt 93 Literaturangaben. Gefördert von: GlaxoSmithKline Biologicals SA/NV, Pfizer Inc, UCB Pharma GmbH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Molecular Targeted TherapyRheumatologyRheumatic DiseasesAntirheumatic AgentsHumansArthritis, RheumatoidOsteoarthritisArthritis, PsoriaticLupus Erythematosus, SystemicScleroderma, Systemic

Substanzen

Antirheumatic Agents

Autor:innen und Institutionen

  • Oregon Health and Science University, Portland, OR, USA. Electronic address: Winthrop@ohsu.edu.
  • Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA; Division of Rheumatology, Department of Medicine, Medical University of Vienna, Vienna, Austria.
  • Translational and Clinical Research Institute, Newcastle University and Musculoskeletal Unit, Newcastle Hospitals, Newcastle upon Tyne, UK.
  • Swedish Medical Center, University of Washington, Seattle, WA, USA.
  • Rheumazentrum Ruhrgebiet, Ruhr University Bochum, Herne, Germany.
  • Mary Kirkland Center for Lupus Research, Hospital for Special Surgery, New York, NY, USA.

Förderung

  • GlaxoSmithKline Biologicals SA/NV
  • Pfizer Inc
  • UCB Pharma GmbH
  • Bristol Myers Squibb Canada Company
  • Eli Lilly and Company
  • Tanabe Pharma Corporation
  • Novartis Pharmaceuticals Corporation
  • Chugai Pharmaceutical Co Ltd

Zitieren

APA

Winthrop, K. L., Kerschbaumer, A., Isaacs, J. D., Mease, P., Baraliakos, X., Crow, M. K., Buch, M., Siebert, S., Basu, N., Conaghan, P., Kloppenburg, M., Distler, O., Landewe, R., Orange, D. E., Wei, K., Aletaha, D., McInnes, I. B., Huizinga, T. W. J., Voll, R., …, & Smolen, J. S. (2026). Chasing the target: reports from the Advances in Targeted Therapies meeting, 2025. Annals of the Rheumatic Diseases. https://doi.org/10.1016/j.ard.2026.03.024

Vancouver

Winthrop KL, Kerschbaumer A, Isaacs JD, Mease P, Baraliakos X, Crow MK, et al. Chasing the target: reports from the Advances in Targeted Therapies meeting, 2025. Annals of the Rheumatic Diseases. 2026. doi:10.1016/j.ard.2026.03.024

BibTeX
@article{Winthrop2026,
  author = {Winthrop, Kevin L and Kerschbaumer, Andreas and Isaacs, John D and Mease, Philip and Baraliakos, Xenofon and Crow, Mary K and Buch, Maya and Siebert, Stefan and Basu, Neil and Conaghan, Philip and Kloppenburg, Margreet and Distler, Oliver and Landewe, Robert and Orange, Dana E and Wei, Kevin and Aletaha, Daniel and McInnes, Iain B and Huizinga, Thomas W J and Voll, Reinhard and Gravallese, Ellen M and Breedveld, Ferdinand C and Smolen, Josef S},
  title = {Chasing the target: reports from the Advances in Targeted Therapies meeting, 2025},
  journal = {Annals of the Rheumatic Diseases},
  year = {2026},
  doi = {10.1016/j.ard.2026.03.024}
}
Kostenlos starten →